Top Headlines

(Image: Getty/bong hyungjung)

The sartan saga: Recapping the recalls

After 2018 saw numerous sartan drugs recalled for possible carcinogenic impurities, in 2019, the industry kept an eye on the regulatory issues that followed and the breakthroughs that have mitigated some of the risks.

Global Industry News

Hot Topics

Spotlight

Follow us

Products

View more

Featured Suppliers

All suppliers